MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.410
+0.070 (5.22%)
At close: Oct 9, 2026, 4:00 PM EDT
1.400
-0.010 (-0.71%)
After-hours: Oct 9, 2026, 7:30 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year. That makes MetaVia the 40,706th largest employer in the world and 6,180th in the United States.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,805,750
Market Cap
9.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | -3 | -60.00% |
| Dec 31, 2021 | 5 | -2 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 39 |
| Lisata Therapeutics | 21 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| Lantern Pharma | 16 |
| CalciMedica | 15 |
| BioVie | 13 |
| Purple Biotech | 10 |
MTVA News
- 4 weeks ago - MetaVia reports results from DA-1726-derived radioactivity study - TheFly
- 4 weeks ago - MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction - PRNewsWire
- 2 months ago - MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - MetaVia Earnings release: Q2 2026 - Filings
- 2 months ago - MetaVia Quarterly report: Q2 2026 - Filings
- 2 months ago - MetaVia Slides: Investor presentation - Filings
- 3 months ago - MetaVia announces completion of dose titration in Phase 1 study of DA-1726 - TheFly
- 3 months ago - MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity - PRNewsWire